State Street’s LeMaitre Vascular LMAT Stock Holding History

State Street’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93.4M	Buy	855,784 +48,791	+6%	+$4.65M	﹤0.01%	1414
2025 Q4	$65.4M	Buy	806,993 +6,130	+0.8%	+$528K	﹤0.01%	1594
2025 Q3	$70.1M	Sell	800,863 -9,566	-1%	-$854K	﹤0.01%	1559
2025 Q2	$67.3M	Buy	810,429 +193	+0%	+$16.1K	﹤0.01%	1524
2025 Q1	$68M	Sell	810,236 -33,508	-4%	-$3.12M	﹤0.01%	1483
2024 Q4	$77.7M	Buy	843,744 +21,659	+3%	+$2.08M	﹤0.01%	1500
2024 Q3	$76.4M	Buy	822,085 +28,525	+4%	+$2.47M	﹤0.01%	1481
2024 Q2	$65.3M	Buy	793,560 +425	+0.1%	+$31.2K	﹤0.01%	1521
2024 Q1	$52.6M	Sell	793,135 -3,552	-0.4%	-$219K	﹤0.01%	1699
2023 Q4	$45.2M	Buy	796,687 +14,742	+2%	+$772K	﹤0.01%	1754
2023 Q3	$42.6M	Buy	781,945 +1,586	+0.2%	+$94K	﹤0.01%	1719
2023 Q2	$52.5M	Buy	780,359 +34,233	+5%	+$2.09M	﹤0.01%	1643
2023 Q1	$38.4M	Buy	746,126 +9,572	+1%	+$465K	﹤0.01%	1821
2022 Q4	$33.9M	Buy	736,554 +26,512	+4%	+$1.24M	﹤0.01%	1895
2022 Q3	$36M	Sell	710,042 -44,024	-6%	-$2.2M	﹤0.01%	1828
2022 Q2	$34.3M	Buy	754,066 +44,301	+6%	+$1.98M	﹤0.01%	1880
2022 Q1	$33M	Sell	709,765 -35,776	-5%	-$1.6M	﹤0.01%	2034
2021 Q4	$37.4M	Sell	745,541 -14,768	-2%	-$764K	﹤0.01%	2017
2021 Q3	$40.4M	Buy	760,309 +63,988	+9%	+$3.6M	﹤0.01%	1967
2021 Q2	$42.5M	Buy	696,321 +17,001	+3%	+$903K	﹤0.01%	1967
2021 Q1	$33.1M	Buy	679,320 +21,130	+3%	+$990K	﹤0.01%	2038
2020 Q4	$26.7M	Sell	658,190 -5,002	-0.8%	-$179K	﹤0.01%	2061
2020 Q3	$21.6M	Sell	663,192 -62,679	-9%	-$1.88M	﹤0.01%	1995
2020 Q2	$19.2M	Buy	725,871 +55,268	+8%	+$1.44M	﹤0.01%	2054
2020 Q1	$16.7M	Buy	670,603 +14,244	+2%	+$440K	﹤0.01%	1953
2019 Q4	$23.6M	Buy	656,359 +39,113	+6%	+$1.35M	﹤0.01%	2030
2019 Q3	$21.1M	Sell	617,246 -49,003	-7%	-$1.57M	﹤0.01%	2027
2019 Q2	$18.6M	Buy	666,249 +59,140	+10%	+$1.64M	﹤0.01%	2153
2019 Q1	$18.9M	Buy	607,109 +11,973	+2%	+$320K	﹤0.01%	2076
2018 Q4	$14.1M	Sell	595,136 -53,788	-8%	-$1.47M	﹤0.01%	2230
2018 Q3	$25.1M	Buy	648,924 +82,600	+15%	+$2.98M	﹤0.01%	2027
2018 Q2	$19M	Buy	566,324 +96,138	+20%	+$3.42M	﹤0.01%	2163
2018 Q1	$17M	Sell	470,186 -17,418	-4%	-$603K	﹤0.01%	2161
2017 Q4	$15.5M	Buy	487,604 +40,649	+9%	+$1.39M	﹤0.01%	2221
2017 Q3	$16.7M	Buy	446,955 +64,131	+17%	+$2.18M	﹤0.01%	2149
2017 Q2	$12M	Buy	382,824 +77,009	+25%	+$2.22M	﹤0.01%	2307
2017 Q1	$7.53M	Sell	305,815 -24,062	-7%	-$565K	﹤0.01%	2503
2016 Q4	$8.36M	Buy	329,877 +37,142	+13%	+$824K	﹤0.01%	2431
2016 Q3	$5.81M	Buy	292,735 +1,006	+0.3%	+$17.6K	﹤0.01%	2472
2016 Q2	$4.16M	Sell	291,729 -6,148	-2%	-$94K	﹤0.01%	2695
2016 Q1	$4.62M	Buy	297,877 +12,189	+4%	+$175K	﹤0.01%	2589
2015 Q4	$4.93M	Buy	285,688 +61,972	+28%	+$897K	﹤0.01%	2542
2015 Q3	$2.73M	Buy	223,716 +40,155	+22%	+$515K	﹤0.01%	2853
2015 Q2	$2.21M	Buy	+183,561	New	+$1.81M	﹤0.01%	3032

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street's LMAT Position: Q1 2026 in Review

State Street increased its LeMaitre Vascular (LMAT) stake by 6% in Q1 2026, buying an estimated $4.65M and bringing the position to 855,784 shares worth $93.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

State Street first reported a position in LMAT in Q2 2015 and has held it in 44 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

State Street held 855,784 shares of LeMaitre Vascular worth $93.4M as of Q1 2026.
State Street bought 48,791 LeMaitre Vascular shares in Q1 2026, an estimated $4.65M.
LeMaitre Vascular made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1414 holding.
State Street first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 44 quarters since.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.